Figure 1. Incidence of Hyperbilirubinemia among Patients Taking Atazanavir in the HIV Outpatient Study (HOPS)

Figure 1. Incidence of Hyperbilirubinemia among Patients Taking Atazanavir in the HIV Outpatient Study (HOPS)

From: Ward D, Curtin J, Richardson J, et al. Hyperbilirubinemia among patients in the HIV Outpatient Study (HOPS) receiving atazanavir. In: The 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, 2005. Abstract TuPe2.1B02.

[Close Window]

From: HIV Web Study <www.hivwebstudy.org>
© 2006-08 University of Washington